Dr. Reddy's Laboratories Ltd. closed 10.04% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Hyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

On the NSE, 14 out of the 15 sectors ended in the red, with the Nifty Media, Energy, Defence and Oil & Gas declining the most ...

Markets tumble as Nifty falls below 25,000 due to FII selling and mixed earnings, impacting investor sentiment.

Markets plunge on weak global cues and earnings, with Nifty breaching critical support; pharmaceutical stocks shine amidst ...

Shares of leather, pharma and textiles companies were in the limelight on Friday after India and the UK signed a landmark free trade agreement. The deal, w ...

Shares of companies related to sectors such as leather, textiles and pharma were in the limelight on Friday morning trade after India and the UK signed a landmark free trade agreement.      The deal, ...

Benchmark NSE Nifty50 index ended down 225.1 points at 24837.0, while the BSE Sensex stood down 721.08 points at 81463.09.

Cipla reports a 10% YoY rise in Q1FY26 net profit, driven by strong performance in consumer healthcare and generics. The ...